Greylin Investment Mangement Inc Amgen Inc Transaction History

Greylin Investment Mangement Inc

  • $566 Million
  • Q2 2024

A detailed history of Greylin Investment Mangement Inc transactions in Amgen Inc stock. As of the latest transaction made, Greylin Investment Mangement Inc holds 14,971 shares of AMGN stock, worth $4.41 Million. This represents 0.83% of its overall portfolio holdings.

Number of Shares
14,971
Previous 15,860 5.61%
Holding current value
$4.41 Million
Previous $4.51 Million 3.73%
% of portfolio
0.83%
Previous 0.76%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024
SELL
$262.75 - $319.31 $233,584 - $283,866
-889 Reduced 5.61%
14,971 $4.68 Million
Q1 2024

Apr 24, 2024
SELL
$268.87 - $324.56 $3.95 Million - $4.77 Million
-14,707 Reduced 48.11%
15,860 $4.51 Million
Q4 2023

Jan 25, 2024
SELL
$255.7 - $288.46 $1.03 Million - $1.16 Million
-4,034 Reduced 11.66%
30,567 $8.8 Million
Q3 2023

Oct 10, 2023
SELL
$218.65 - $271.46 $808,349 - $1 Million
-3,697 Reduced 9.65%
34,601 $9.3 Million
Q2 2023

Jul 10, 2023
BUY
$214.27 - $253.37 $61,281 - $72,463
286 Added 0.75%
38,298 $8.5 Million
Q1 2023

Apr 07, 2023
SELL
$225.79 - $275.2 $92,799 - $113,107
-411 Reduced 1.07%
38,012 $9.19 Million
Q4 2022

Jan 25, 2023
SELL
$229.03 - $291.01 $65,273 - $82,937
-285 Reduced 0.74%
38,423 $0
Q3 2022

Oct 13, 2022
SELL
$224.46 - $253.15 $311,326 - $351,119
-1,387 Reduced 3.46%
38,708 $8.73 Million
Q2 2022

Jul 11, 2022
SELL
$230.71 - $256.74 $99,666 - $110,911
-432 Reduced 1.07%
40,095 $9.76 Million
Q1 2022

May 20, 2022
BUY
$219.27 - $242.57 $119,282 - $131,958
544 Added 1.36%
40,527 $9.8 Million
Q4 2021

Feb 15, 2022
BUY
$198.88 - $227.6 $3.56 Million - $4.07 Million
17,892 Added 80.99%
39,983 $9 Million
Q3 2021

Oct 13, 2021
BUY
$212.27 - $248.7 $4.26 Million - $4.99 Million
20,046 Added 980.24%
22,091 $4.7 Million
Q2 2021

Jul 14, 2021
BUY
$233.58 - $259.14 $32,934 - $36,538
141 Added 7.41%
2,045 $498,000
Q1 2021

May 12, 2021
BUY
$221.91 - $258.6 $29,292 - $34,135
132 Added 7.45%
1,904 $474,000
Q4 2020

Jan 14, 2021
BUY
$216.38 - $257.67 $2,163 - $2,576
10 Added 0.57%
1,772 $407,000
Q3 2020

Oct 13, 2020
SELL
$234.65 - $260.95 $888,150 - $987,695
-3,785 Reduced 68.24%
1,762 $448,000
Q2 2020

Aug 13, 2020
SELL
$197.81 - $242.74 $343,200 - $421,153
-1,735 Reduced 23.83%
5,547 $1.31 Million
Q1 2020

Apr 09, 2020
SELL
$182.24 - $241.7 $957,671 - $1.27 Million
-5,255 Reduced 41.92%
7,282 $1.48 Million
Q4 2019

Jan 09, 2020
SELL
$189.21 - $243.2 $628,177 - $807,424
-3,320 Reduced 20.94%
12,537 $3.02 Million
Q3 2019

Oct 11, 2019
SELL
$174.11 - $208.62 $9,576 - $11,474
-55 Reduced 0.35%
15,857 $3.07 Million
Q2 2019

Aug 15, 2019
BUY
$166.7 - $195.41 $530,106 - $621,403
3,180 Added 24.98%
15,912 $2.93 Million
Q1 2019

Apr 09, 2019
SELL
$180.87 - $203.88 $45,217 - $50,970
-250 Reduced 1.93%
12,732 $2.42 Million
Q4 2018

Jan 14, 2019
SELL
$178.4 - $208.25 $495,060 - $577,893
-2,775 Reduced 17.61%
12,982 $2.53 Million
Q3 2018

Nov 14, 2018
BUY
$185.29 - $208.89 $4,632 - $5,222
25 Added 0.16%
15,757 $3.27 Million
Q2 2018

Aug 07, 2018
BUY
$166.05 - $186.51 $214,536 - $240,970
1,292 Added 8.95%
15,732 $2.9 Million
Q1 2018

May 14, 2018
BUY
$169.43 - $198.0 $9,318 - $10,890
55 Added 0.38%
14,440 $2.46 Million
Q4 2017

Jan 16, 2018
BUY
$168.79 - $188.59 $55,363 - $61,857
328 Added 2.33%
14,385 $2.5 Million
Q3 2017

Nov 14, 2017
BUY
$167.29 - $191.0 $2.35 Million - $2.68 Million
14,057
14,057 $2.62 Million

Others Institutions Holding AMGN

# of Institutions
3,122
Shares Held
410M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Greylin Investment Mangement Inc Portfolio

Follow Greylin Investment Mangement Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greylin Investment Mangement Inc, based on Form 13F filings with the SEC.

News

Stay updated on Greylin Investment Mangement Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email